| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94901d0a24b020cb15ff36f1e7364779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb2648e65ad8850515bd727a122f1186 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
| filingDate |
2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49607b9ace090dc106976f3c511757d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460a033b43a59faf1b75388f31113dc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5d2753b0e906a6d002c8a73c4b220a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d12c4611b08b111947a058b60ce0b643 |
| publicationDate |
2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015004347-A1 |
| titleOfInvention |
Medication on the basis of xenon, preferably in combination with an nmda receptor antagonist, for fighting the neurogenerative disorder parkinson's disease |
| abstract |
The invention relates to a gaseous medication containing xenon, to be used by inhalation for treating, slowing or preventing neurological deterioration resulting from Parkinson's disease in a human patient. The medication preferably contains between 10 and 80% by volume xenon. The gaseous medication containing xenon is advantageously used in combination with at least one NMDA receptor antagonist such as memantine or nitromemantine, in liquid or solid form, in particular in the form of a tablet or gel capsule. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3027226-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016059307-A1 |
| priorityDate |
2013-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |